BU — Burcon NutraScience Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapSucker Stock

Annual income statement for Burcon NutraScience, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.259	0.171	0.364	0.184	0.381
Cost of Revenue
Gross Profit	-0.527	-1.28	—	—	-0.329
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	4.85	7.57	15.9	7.2	8.08
Operating Profit	-4.6	-7.4	-15.5	-7.02	-7.7
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.617	-10.3	-25.4	-7.45	-8.26
Net Income After Taxes	-0.617	-10.3	-25.4	-7.45	-8.26
Net Income Before Extraordinary Items
Net Income	-0.617	-10.3	-25.4	-7.45	-8.26
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.617	-10.3	-25.4	-7.45	-8.26
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.099	-1.56	-2.64	-1.01	-0.988